FIELD: chemistry.
SUBSTANCE: invention relates to compounds of formula IB: (IB), where Ar is phenyl or benzyl; R1 denotes -NRaRb, where Ra denotes H, and Rb denotes phenyl; 5-9-member heterocycloalkyl, containing 1 or 2 heteroatoms, independently selected from N or O; 6-10-member aryl; 5-14-member heteroaryl containing 1 or 2 heteroatoms, independently selected from N, S or O; each of said heterocycloalkyl, aryl or heteroaryl is not substituted or is substituted with 1 or 2 substitutes, which can be identical or different, and are independently selected from a group consisting of deuterium, halogen, cyano, C1-C6-alkyl, hydroxyl, hydroxyalkyl, hydroxyalkoxy, halogen-C1-C6-alkyl, alkoxy, halogen-C1-C6-alkoxy, -(CH2)q-NRcRd, -(CH2)q-CONRcRd, -S(O)2-C1-C6-alkyl, -S(O)2NH2, -C(O)O-C1-C6-alkyl, phenyl, 5-member -(CH2)qheteroaryl, containing 1 or 2 heteroatoms, independently selected from N, and 5-6-member -(CH2)qheterocycloalkyl containing 1 or 2 heteroatoms, independently selected from N or O, wherein each of said heterocycloalkyl or heteroaryl can be substituted with one or more halogen, nitro, halogen-C1-C6-alkyl, halogenalkoxy, oxo, cyano, C1-C6-alkyl or alkoxy, and Rc and Rd are independently selected from a group, consisting of H, C1-C6-alkyl and 3-5-member cycloalkyl; q is equal to 0; for inhibiting NAMPT, their synthesis, use and antidotes.
EFFECT: novel compounds and compositions for inhibiting NAMPT.
26 cl, 3 tbl, 8 ex
Title | Year | Author | Number |
---|---|---|---|
GUANIDINE COMPOUNDS AND COMPOSITIONS FOR INHIBITING NAMPT | 2011 |
|
RU2593759C2 |
NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITING NAMPT | 2011 |
|
RU2617424C2 |
NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITING NAMPT | 2011 |
|
RU2617643C2 |
NEW COMPOUNDS AND COMPOSITIONS FOR NAMPT INHIBITION | 2011 |
|
RU2617988C2 |
HYDROXAMATE DERIVATIVES SUITABLE AS DEACETYLASE INHIBITORS | 2001 |
|
RU2302408C2 |
APOPTOSIS INDUCING AGENTS FOR TREATING CANCER AND IMMUNE AND AUTOIMMUNE DISEASES | 2010 |
|
RU2538965C2 |
APOPTOSIS-INDUCING AGENTS FOR TREATING CANCER AND IMMUNE AND AUTOIMMUNE DISEASES | 2010 |
|
RU2539587C2 |
PYRROLO[2,3-b]PYRIDINE DERIVATIVES INHIBITING ACTIVITY OF ANTI-APOPTOTIC Bcl-2 PROTEINS | 2011 |
|
RU2567857C2 |
HYDROXYETHYLAMINOSULFONEAMIDES, INTERMEDIATE COMPOUNDS, PHARMACEUTICAL COMPOSITION, METHOD OF INHIBITION RETROVIRAL PROTEASES, METHOD OF TREATMENT OF RETROVIRAL INFECTIONS, METHOD OF TREATMENT OF AIDS | 1993 |
|
RU2173680C2 |
APOPTOSIS-INDUCING PREPARATIONS FOR TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES | 2009 |
|
RU2527450C2 |
Authors
Dates
2017-04-18—Published
2011-09-02—Filed